This public procurement record has 3 releases in its history.

Award

13 Oct 2026 at 12:24

Award

22 Jul 2026 at 10:17

Award

15 Jul 2026 at 13:36

Summary of the contracting process

Cell Therapy Catapult Limited procured non-GMP alternating tangential flow (ATF) laboratory equipment for process development at CGTC Braintree. The work supports development of a biotherapeutic manufacturing process intended to transfer subsequently into GMP production. The purchase covers the equipment, a one-year warranty and options for a further one-year service contract and spare parts for maintenance. This is specialist biomedical laboratory equipment, with related maintenance services. The equipment is intended to support development using the same ATF technology as the planned GMP manufacturing system, allowing the process to be developed at laboratory scale before transfer. The delivery location is Braintree.

The procurement is complete and the contract has been awarded to Repligen B.V. through a direct award, justified on the grounds that only this supplier could meet the technical requirement and there were no reasonable alternatives. The award was dated 22 July 2026. The signed contract is valued at €254,479 excluding VAT (€305,375 including VAT); the award value was €288,232 excluding VAT (€345,878.40 including VAT). The contract was signed on 29 September 2026 and runs from 29 September 2026 to 23 October 2027. The award period is stated as 13 October 2026 to 12 October 2027, with a maximum extent to 12 October 2028. The procurement was organised as one lot. Evaluation was not competitive: the stated basis was technical exclusivity, including compatibility with the buyer’s planned GMP ATF system and suitability for perfusion applications.

This purchase is most relevant to suppliers of specialist single-use ATF perfusion systems for biotherapeutic process development, particularly those able to supply laboratory-scale equipment that is compatible with a corresponding GMP manufacturing system. The buyer’s rationale points to a need for process continuity between development and GMP production, effective connection with Thermo Fisher Dynadrive bioreactors, and process intensity suitable for reducing manufacturing costs. General TFF filtration or acoustic perfusion systems may not meet this specific need where they are unsuitable for perfusion or require substantial re-engineering to interface with existing equipment. A credible competitor would therefore need proven technical compatibility, relevant perfusion capability and equipment suitable for non-GMP development ahead of transfer into GMP manufacturing, together with warranty, service and spare-parts support.

How relevant is this notice?

Notice Information

Notice Title

Purchase of Alternating Tangential Flow (ATF) Non-GMP Equipment

Notice Description

CGTC Braintree plans to procure Non-GMP Alternating Tangential Flow (ATF) equipment to support process development activities that will subsequently be transferred to GMP manufacturing. The procurement includes a one year equipment warranty and the option to enter into an additional one-year service contract. The total value of the procurement is EUR254,479 (excluding VAT).

Procurement Information

Schedule 5, paragraph 6 of the Procurement Act 2023 provides for the following justification for directly awarding contracts where there is only a single supplier who can meet the requirement: "The following conditions are met in relation to the public contract- (a)due to an absence of competition for technical reasons, only a particular supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works." This purchase is for a lab base non-GMP system, but it is required to support the development of the process that will be transferred to GMP Manufacturing. A Repligen system will be used in GMP Manufacturing for the reasons listed below, and therefore the corresponding smaller scale lab system is required for this purchase. Repligen are the only supplier of GMP Perfusion equipment that operates using Alternating Tangential Flow. There is no other commercially available system that can perform single use ATF style perfusion suitable for use in a GMP cleanroom. ATF style perfusion has been selected for this project as it is technically superior to the alternative TFF (Tangential Flow Filtration)-based or acoustic-based perfusion devices and there is wider industry adoption of ATF for use in bio-therapeutic manufacturing operations for this reason. Alternative suppliers found from online searches have single-use TFF systems available such as the Sartorius Sartoflow 5000 SU TFF System, but these are not suitable for use in perfusion applications and are not proven to readily connect with Thermo Fisher Dynadrive bioreactors. Extensive re-engineering of BMIC existing systems would need to take place in order to interface these devices and even then it is unlikely to achieve the process intensity outputs required for a suitable reduction in the cost of goods.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06cbf5
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/096501-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

38 - Laboratory, optical and precision equipments (excl. glasses)

50 - Repair and maintenance services


CPV Codes

38434540 - Biomedical equipment

50400000 - Repair and maintenance services of medical and precision equipment

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£288,232 £100K-£500K
Contracts Value
£254,479 £100K-£500K

Notice Dates

Publication Date
13 Oct 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
22 Jul 20263 months ago
Contract Period
29 Sep 2026 - 23 Oct 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
CELL THERAPY CATAPULT LIMITED
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 9RT
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI44 Lewisham and Southwark
Delivery Location
Not specified

Local Authority
Southwark
Electoral Ward
London Bridge & West Bermondsey
Westminster Constituency
Bermondsey and Old Southwark

Supplier Information

Number of Suppliers
1
Supplier Name

Repligen B.V

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...